|
| Press Releases |
|
 |
|
| Friday, August 29, 2025 |
|
|
AI-Powered Foundation, Innovation-Driven Empowerment, Legend Holdings Reports RMB699 Million in Net Profit Attributable to Parent for 2025H1 |
| Legend Holdings Corporation ('Legend Holdings' or the 'Company'; Stock Code: 3396.HK) today announced its unaudited condensed consolidated interim results for the six months ended June 30, 2025 (the 'Reporting Period'). more info >> |
|
| Friday, March 28, 2025 |
|
|
Legend Holdings Delivers Significant Recovery in 2024 Performance |
| "Legend Holdings Corporation ("Legend Holdings" or the "Company"; Stock Code: 3396.HK) announced the audited annual results for the year ended December 31, 2024 (the "Reporting Period"). more info >> |
|
| Friday, August 30, 2024 |
|
|
Legend Holdings Recorded a Revenue of RMB233.4 Billion in H1 2024 |
| Legend Holdings Corporation ('Legend Holdings' or the 'Company', Stock Code: 3396. HK) announces the unaudited condensed consolidated interim results of the Group for the six months ended 30 June 2024 (the 'Reporting Period'). more info >> |
|
| Friday, March 29, 2024 |
|
|
Legend Holdings Realized Revenue of RMB436 billion in 2023 |
| more info >> |
|
| Thursday, August 31, 2023 |
|
|
Legend Holdings Released 2023 Interim Results, Stepping up Investment in Technological Innovation to Accumulate High-quality Development Momentum |
| On August 31, 2023, Legend Holdings Corporation (3396.HK) announced the unaudited condensed consolidated interim results for the six months ended June 30, 2023 (the "Reporting Period"). more info >> |
|
| Friday, March 31, 2023 |
|
Expand Investment in Science and Technology and Empower Industry Development, Legend Holdings Realized Revenue of RMB483.7 billion by 2022
|
Legend Holdings Corporation (stock code: 3396.HK) announced its audited annual results for the year ended December 31, 2022 (the "Reporting Period") on March 31, 2023. During the Reporting Period, Legend Holdings achieved revenue of RMB483.7 billion and net profit attributable to equity holders of the Company of RMB1.167 billion.
more info >> |
|
| Wednesday, August 31, 2022 |
|
|
Pursued progress while ensuring stability and built up momentum, Legend Holdings realized revenue of RMB237,685 million in the first half of 2022 |
| Legend Holdings Corporation (stock code: 3396.HK) announced today the unaudited condensed consolidated interim results for the six months ended June 30, 2022 (the "Reporting Period"). During the Reporting Period, the Company's revenue was RMB237,685 million and the net profit attributable to equity holders of the Company amounted to RMB2,131 million. more info >> |
|
| Friday, April 1, 2022 |
|
|
Legend Holdings (3396.HK) Announced 2021 Annual Results |
| According to South China Morning Post, Global market experienced another rock year. The impact of COVID-19 still not got away, the chaos of global supply chain showed that the world still need time to recover; more info >> |
|
| Thursday, March 31, 2022 |
|
|
Legend Holdings: Remaining True to the Original Aspiration, Leading by Technology, and Serving the Country through Industry |
| Legend Holdings Corporation (3396.HK) announced today the audited annual results of the 12 months ended December 31, 2021("Reporting Period"). more info >> |
|
| Friday, October 8, 2021 |
|
|
Legend Capital leads ForQaly Medical's Series B financing |
| ForQaly Medical (hereinafter referred to as "ForQaly"), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory assistant devices. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
SGL Golf Launches in U.S. Market to Meet Demand for Autonomous Course Management Solutions 
Feb 3, 2026 3:00 JST
|
|
|
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades
Feb 2, 2026 22:00 HKT/SGT
|
|
|
Hans Vestberg, Former Verizon Chairman and CEO, Joins Digipower X As Senior Advisor
Feb 2, 2026 20:30 HKT/SGT
|
|
|
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
Feb 2, 2026 20:00 HKT/SGT
|
|
|
Lockheed Martin and Fujitsu to accelerate dual-use technology development
Feb 2, 2026 16:29 JST
|
|
|
Fujitsu introduces biometric authentication service for SMBC Nikko Securities Online Trading
Feb 2, 2026 14:30 JST
|
|
|
COSMOPlat, Serving 160,000 Firms, Files for Hong Kong IPO on "AI+Industrial Internet" Wave
Feb 2, 2026 13:29 HKT/SGT
|
|
|
Muyuan Foods IPO: Hog Giant's Profit Growth Outpaces Top 10 Global Meat Firms, Eyes Global Expansion
Feb 2, 2026 13:17 HKT/SGT
|
|
|
JCB Launches Usage Promotion Campaign for Inbound Visitors in Fukuoka's Tenjin Area
Feb 2, 2026 10:00 JST
|
|
|
Web-based tool makes it easier to design advanced materials
Feb 2, 2026 08:00 HKT/SGT
|
|
|
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets
Feb 1, 2026 17:00 HKT/SGT
|
|
|
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre
Jan 31, 2026 21:00 HKT/SGT
|
|
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT/SGT
|
|
|
NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion
Jan 30, 2026 22:50 JST
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
